Pressure BioSciences Inc.

pressure biosciences inc. - All News and Analysis

• Pressure BioSciences, Inc. and Battelle Memorial Institute Sign Exclusive Patent License Agreement

  - 2008-12-22

  SOUTH EASTON, Mass., Dec. 22 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. ("PBI" or the "Company") today announced that they have entered into an exclusive patent license agreement with the Battelle Memorial Institute ("Battelle"). The licensed technology is described in the patent application filed by Battelle on July 31,...

• Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System

  - 2008-12-17

  A Global Biopharmaceutical Company Purchases Two PCT Systems to Help in the Analysis of Therapeutic Proteins SOUTH EASTON, Mass., Dec. 17 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. ("PBI") today announced that they have entered into a collaboration with the J. Craig Venter Institute ("JCVI"), a not for...

• Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement

  - 2008-12-11

  SOUTH EASTON, Mass., Dec. 11 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. ("PBI" or the "Company") and Omni International ("Omni") today announced that they have entered into a strategic marketing, distribution, and technology co-development Agreement. Under the terms of the Agreement, the companies will: (1) share market data, customer leads,...

• Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus

  - 2008-12-01

  SOUTH EASTON, Mass., Dec. 1 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. ("PBI" or the "Company") today announced a comprehensive restructuring program designed to significantly reduce costs, centralize core operations, and refocus the Company's business strategy in specific areas where the Company's products have found significant market acceptance. The...

• Pressure BioSciences, Inc. Reports Record Third Quarter 2008 Financial Results and Provides Business Update

  - 2008-11-17

  SOUTH EASTON, Mass., Nov. 17 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. ("PBI" and the "Company") today announced that total revenue for the third quarter of 2008 was $265,662 compared to $138,052 for the comparable period in the prior year. Revenue from the sale of PCT products and services...

• Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

  - 2008-11-14

  SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live...

• Pressure BioSciences, Inc. Provides Corporate Update

  - 2008-10-08

  SOUTH EASTON, Mass., Oct. 8 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. ("PBI") today provided an update on various corporate activities, including the presentation of favorable data generated by scientists at Amgen, Inc. on the Company's pressure cycling technology ("PCT"), the scheduled presentation by Dr. Paul Pevsner of the NYU...

• Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Update Coverage By Dutton Associates

  - 2008-08-04

  ROSEVILLE, Calif. -- Dutton Associates updates its coverage of Pressure BioSciences (Nasdaq:PBIO) maintaining a Strong Speculative Buy rating and a 12 month target price of $8. The 15-page report by Dutton senior analyst Denise T. Resnik, M.S. is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks,...

• Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Update Coverage By Dutton Associates

  - 2008-04-30

  ROSEVILLE, Calif. -- Dutton Associates updates its coverage of Pressure BioSciences (Nasdaq: PBIO) maintaining a Strong Speculative Buy rating and a 12-month target price of $8. The 15-page report by Dutton senior analyst Denise T. Resnik, M.S. is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks,...

• 5th Annual Taglich Brothers Small Cap Equity Conference

  - 2008-04-21

  The 5th Annual Taglich BrothersSmall Cap Equity Conference will be held in Manhattan at Le ParkerMeridien Hotel on Tuesday, May 6th, 2008. This conference is aunique opportunity for investors to meet the management teams from thefollowing small and microcap companies: Air Industries Group, Inc.AIRI,...

• QualityStocks.net News Pressure BioSciences Inc. (PBIO) Hires Matthew Potter to Join Management Team as the Vice President of Sales - 3/11/08.

  - 2008-03-12

  M2 PRESSWIRE-12 March 2008-QualityStocks: QualityStocks.net News Pressure BioSciences Inc. PBIO Hires Matthew Potter to Join Management Team as the Vice President of Sales - 3/11/08C1994-2008 M2 COMMUNICATIONS LTD RDATE:11032008 At www.QualityStocks.Net you can sign up for Quality Stock's ...

• Progressive Following for Pressure BioSciences, Inc.

  - 2008-03-11

  M2 PRESSWIRE-11 March 2008-Market Review: Progressive Following for Pressure BioSciences, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:11032008 Streetinvesting.com has now resumed our progressive review of Pressure BioSciences, Inc. (Nasdaq: PBIO) after it traded unchanged Tuesday, early in the afternoon with no...

• QualityStocks.net News Pressure BioSciences, Inc. (PBIO) Announces Relocation to New Corporate Offices 3/10/08.

  - 2008-03-11

  M2 PRESSWIRE-11 March 2008-QualityStocks: QualityStocks.net News Pressure BioSciences, Inc. PBIO Announces Relocation to New Corporate Offices 3/10/08C1994-2008 M2 COMMUNICATIONS LTD RDATE:10032008 At www.QualityStocks.Net you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and...

• Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating in Update Coverage by Dutton Associates

  - 2007-12-18

  EL DORADO HILLS, Calif. -- Dutton Associates updates its coverage of Pressure BioSciences (Nasdaq: PBIO) maintaining a Strong Speculative Buy rating and a 12 month target price of $10. The 17-page report by Dutton senior analyst Denise T. Resnik, M.S. is available at www.jmdutton.com as well as from First Call,...

• QualityStocks.net News: Pressure BioSciences to be featured in Small Cap Stock Newsletter QualityStocks Daily

  - 2007-12-06

  SCOTTSDALE, Ariz. -- QualityStocks.net today announced that they will begin to feature Pressure BioSciences, Inc. (NASDAQ: PBIO) in The Small Cap QualityStocks Daily Newsletter, Daily Internet broadcast with Cathy Rankin, Vanessa Ramirez and Jenn Hoffman, and QualityStocks Daily Blogs and Message Boards. QualityStocks.net, based in Scottsdale, Arizona, is a free...

• Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Initiating Coverage By Dutton Associates

  - 2007-09-12

  EL DORADO HILLS, Calif. -- Dutton Associates initiates coverage of Pressure BioSciences (OTCBB:PBIO) with a Strong Speculative Buy rating and a 12 month target price of $10. The 17-page report by Dutton senior analyst Denise T. Resnik, M.S. is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks,...

• Pressure BioSciences issued first patent in Canada.

  - 2007-08-01

  Pressure BioSciences, Inc. (West Bridgewater, MA) has been issued its first patent by the Canadian Intellectual Property Office. Entitled "Pressure-Mediated Binding of Biomolecular Complexes" (Number 2,259,318), this issuance extends the coverage of the company's pressure cycling technology PCT patents previously issued in the United...

• Daily Market Movers Digest Report for Wednesday May 30th, WRNW, SNYL, USXP, GTRE, PBIO.

  - 2007-05-30

  M2 PRESSWIRE-30 May 2007-OTCPicks.com: Daily Market Movers Digest Report for Wednesday May 30th, WRNW, SNYL, USXP, GTRE, PBIOC1994-2007 M2 COMMUNICATIONS LTD RDATE:30052007 Our Stocks to Watch today include Well Renewal Inc (OTC: WRNW), SunnyLife Global (OTC: SNYL), Universal Express (OTCBB: USXP),...

• Taglich Brothers Announces 4th Annual Small Cap Equity Conference

  - 2007-04-30

  Taglich Brothers is pleased to announce our4th Annual Small Cap Equity Conference( http://www.taglich.com/conference.htm ) to be held at Le Parker MeridienHotel, 118 West 57th Street, New York on Tuesday, May 1st, 2007. This conference is a unique opportunity for investors to meet themanagement teams from the following small and microcap...

• ValueRich to Celebrate Successful Expo and Web 2.0 Community Launch at Shore Club in South Beach

  - 2007-03-20

  WEST PALM BEACH, Fla. -- Only one week left to register and join America's premiere celebration of small-caps at the ValueRich Small-cap Financial Expo, March 27-28, 2007, at the InterContinental Miami Hotel, located in the heart of Miami's exploding Brickell Avenue financial district. This year's event showcases 47...

• Incorporated: 1978
• CEO: Mr. Richard T. Schumacher
• Employees: 27